Related Experiment Video
Updated: May 20, 2026
04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Reinforcement, dopamine and rodent models in drug development for ADHD
1Human Developmental Neurobiology Unit, Okinawa Institute of Science and Technology Graduate University, Kunigami, Okinawa 904-0412, Japan. tripp@oist.jp
Summary
Altered dopamine signaling in attention deficit hyperactivity disorder (ADHD) may explain key symptoms. Targeting neural pathways involved in reinforcement could lead to more effective ADHD treatments.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Attention deficit hyperactivity disorder (ADHD) poses unique challenges for pharmaceutical development.
- Current ADHD treatments, including psychostimulants and nonstimulants, are effective but their mechanisms of action are not fully understood at higher levels.
- Altered reinforcement mechanisms are increasingly recognized as a core feature of ADHD.
Purpose of the Study:
- To review evidence linking altered reinforcement mechanisms to ADHD.
- To propose a specific dopamine-related mechanism underlying ADHD symptoms.
- To identify promising targets for future ADHD drug development.
Main Methods:
- Review of existing scientific literature on ADHD, dopamine signaling, and reinforcement.
- Analysis of evidence suggesting a deficit in dopamine signal transfer.
- Theoretical modeling of neural substrates involved in dopamine neuron regulation.
Main Results:
- Evidence suggests altered reinforcement mechanisms are fundamental to ADHD.
- A deficit in transferring dopamine signals from reinforcers to predictive cues may underlie ADHD.
- This deficit could explain key ADHD symptoms.
Conclusions:
- The neural substrates regulating dopamine neuron excitation/inhibition during signal transfer are promising targets for new ADHD drug development.
- Developing animal models and behavioral paradigms is crucial for investigating these mechanisms.
- This approach may enable more specific and selective drug targeting for ADHD.
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...